Invesco’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Invesco’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7	Closed	-$39K	–	3951
2020 Q4	$39K	Buy	+7	New	+$44K	﹤0.01%	3752

Other funds holding YARW

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DAM

Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Invesco's YARW Position: Q1 2021 in Review

Invesco sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q1 2021, closing a stake of 7 shares — an estimated $39K sold.

Invesco first reported a position in YARW in Q4 2020 and held it in 1 quarter. The position peaked at $39K in Q4 2020. 81 funds tracked by Wall St. Rank hold YARW as of Q1 2021.

Invesco reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Invesco sold 7 Yarrow Bioscience, Inc. Common Stock shares in Q1 2021, an estimated $39K.
Invesco first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Invesco's Yarrow Bioscience, Inc. Common Stock position peaked at $39K in Q4 2020.
81 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2021.

Based on Invesco's 13F filing for Q1 2021, filed 17 May 2021.